VAV2 and Hyperglycemia: Mice with a mutation that reduces the activity of Vav2 exhibit low skeletal muscle mass, hyperglycaemia, glucose intolerance, increased adiposity, and liver steatosis10, whereas mice with hyperactive Vav2 show increased muscle mass and resistance to developing metabolic syndrome10–12.